nodes	percent_of_prediction	percent_of_DWPC	metapath
Biperiden—CHRM1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0494	0.0494	CbGpPWpGaD
Biperiden—CHRM2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0487	0.0487	CbGpPWpGaD
Biperiden—CHRM1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0421	0.0421	CbGpPWpGaD
Biperiden—CHRM2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0416	0.0416	CbGpPWpGaD
Biperiden—CHRM1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0409	0.0409	CbGpPWpGaD
Biperiden—CHRM2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0404	0.0404	CbGpPWpGaD
Biperiden—CHRM1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0381	0.0381	CbGpPWpGaD
Biperiden—CHRM2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0376	0.0376	CbGpPWpGaD
Biperiden—CHRM1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0354	0.0354	CbGpPWpGaD
Biperiden—CHRM2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0349	0.0349	CbGpPWpGaD
Biperiden—CHRM1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0344	0.0344	CbGpPWpGaD
Biperiden—CHRM2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0339	0.0339	CbGpPWpGaD
Biperiden—CHRM1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.032	0.032	CbGpPWpGaD
Biperiden—CHRM2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0316	0.0316	CbGpPWpGaD
Biperiden—CHRM1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0267	0.0267	CbGpPWpGaD
Biperiden—CHRM2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0263	0.0263	CbGpPWpGaD
Biperiden—CHRM1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0224	0.0224	CbGpPWpGaD
Biperiden—CHRM2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0221	0.0221	CbGpPWpGaD
Biperiden—CHRNA2—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.0215	0.0215	CbGpPWpGaD
Biperiden—CHRM2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.0185	0.0185	CbGpPWpGaD
Biperiden—CHRM2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.0179	0.0179	CbGpPWpGaD
Biperiden—CHRNA2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.0165	0.0165	CbGpPWpGaD
Biperiden—CHRM2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.0117	0.0117	CbGpPWpGaD
Biperiden—CHRM1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00992	0.00992	CbGpPWpGaD
Biperiden—CHRM1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00963	0.00963	CbGpPWpGaD
Biperiden—CHRM1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.00897	0.00897	CbGpPWpGaD
Biperiden—CHRM2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00864	0.00864	CbGpPWpGaD
Biperiden—CHRM2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00839	0.00839	CbGpPWpGaD
Biperiden—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00813	0.00813	CbGpPWpGaD
Biperiden—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00802	0.00802	CbGpPWpGaD
Biperiden—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00789	0.00789	CbGpPWpGaD
Biperiden—CHRM2—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00782	0.00782	CbGpPWpGaD
Biperiden—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00779	0.00779	CbGpPWpGaD
Biperiden—CHRM2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.0076	0.0076	CbGpPWpGaD
Biperiden—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00735	0.00735	CbGpPWpGaD
Biperiden—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00725	0.00725	CbGpPWpGaD
Biperiden—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00696	0.00696	CbGpPWpGaD
Biperiden—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00687	0.00687	CbGpPWpGaD
Biperiden—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00676	0.00676	CbGpPWpGaD
Biperiden—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00667	0.00667	CbGpPWpGaD
Biperiden—CHRM1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00666	0.00666	CbGpPWpGaD
Biperiden—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.0063	0.0063	CbGpPWpGaD
Biperiden—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00622	0.00622	CbGpPWpGaD
Biperiden—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00596	0.00596	CbGpPWpGaD
Biperiden—CHRM1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.0053	0.0053	CbGpPWpGaD
Biperiden—CHRM2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00523	0.00523	CbGpPWpGaD
Biperiden—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00515	0.00515	CbGpPWpGaD
Biperiden—CHRM1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00515	0.00515	CbGpPWpGaD
Biperiden—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00508	0.00508	CbGpPWpGaD
Biperiden—CHRM2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00508	0.00508	CbGpPWpGaD
Biperiden—CHRM1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00479	0.00479	CbGpPWpGaD
Biperiden—CHRM2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00473	0.00473	CbGpPWpGaD
Biperiden—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00441	0.00441	CbGpPWpGaD
Biperiden—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00435	0.00435	CbGpPWpGaD
Biperiden—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00336	0.00336	CbGpPWpGaD
Biperiden—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00331	0.00331	CbGpPWpGaD
Biperiden—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	0.00322	0.00322	CbGpPWpGaD
Biperiden—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	0.00303	0.00303	CbGpPWpGaD
Biperiden—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.003	0.003	CbGpPWpGaD
Biperiden—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00296	0.00296	CbGpPWpGaD
Biperiden—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00291	0.00291	CbGpPWpGaD
Biperiden—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00287	0.00287	CbGpPWpGaD
Biperiden—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00272	0.00272	CbGpPWpGaD
Biperiden—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00271	0.00271	CbGpPWpGaD
Biperiden—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00269	0.00269	CbGpPWpGaD
Biperiden—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00267	0.00267	CbGpPWpGaD
Biperiden—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00264	0.00264	CbGpPWpGaD
Biperiden—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00261	0.00261	CbGpPWpGaD
Biperiden—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00246	0.00246	CbGpPWpGaD
Biperiden—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00243	0.00243	CbGpPWpGaD
Biperiden—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00239	0.00239	CbGpPWpGaD
Biperiden—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.0019	0.0019	CbGpPWpGaD
Biperiden—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00187	0.00187	CbGpPWpGaD
Biperiden—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00172	0.00172	CbGpPWpGaD
Biperiden—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.0017	0.0017	CbGpPWpGaD
Biperiden—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00161	0.00161	CbGpPWpGaD
Biperiden—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00159	0.00159	CbGpPWpGaD
Biperiden—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00156	0.00156	CbGpPWpGaD
Biperiden—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00154	0.00154	CbGpPWpGaD
Biperiden—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00145	0.00145	CbGpPWpGaD
Biperiden—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00143	0.00143	CbGpPWpGaD
Biperiden—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00102	0.00102	CbGpPWpGaD
Biperiden—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.001	0.001	CbGpPWpGaD
